1Ito T, Tanaka M, Sasano H, et al. Neuroendocrine Tumor Workshop of Japan. Preliminary results of a Japanese nationwide survey of neuroendocrine gastrointestinal tumors[J]. J Gastroenterol, 2007,42 (6):497-500.
2Pape U F, Bohmig M, Berndt U, et al. Survival and clinical outcome of patients with neuroendocrine tumors of the gastroenteropancreatic tract in a german referral center[J]. Ann N Y Acad Sci, 2004,1014 : 222-233.
3Nikou G C, Lygidakis N J, Toubanakis C, et al. Current diag- nosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin. A, somatostatin receptor scintigraphy and somatostatin analogues [J]. Hepatogastroenterology, 2005,52 (63) : 731-741.
4Rindi G, Bordi C. Highlights of the biology of endocrine tumours of the gut and pancreas[J]. Endocr Relat Cancer, 2003, 10 (4): 427- 436.
5Rindi G, Ubiali A, Villanacci V. The phenotype of gut endocrine tumours[J]. Dig Liver Dis, 2004,36(Suppl 1):S26-30.
6Rindi G, Bordi C. Endocrine tumours of the gastrointestinal tract: aetiology, molecular pathogenesis and geneties[J]. Best Pract Res Clin Gastroenterol,2005,19(4) :519-534.
7Cimitan M, Buonadonna A, Cannizzaro R, et al. Somatostatin receptor scintigraphy versus chromogranin A assay in the management of patients with neuroendocrine tumors of different types: clinical role[J]. Ann Oncol,2003,14(7) :1135-1141.
8Panzuto F, Falconi M, Nasoni S, et al. Staging of digestive endocrine tumours using helical computed tomography and somatostatin receptor scintigraphy [J]. Ann Oncol, 2003, 14 (4):586-591.
9Oberg K. Neuroendocrine gastrointestinal tumours[J]. Ann Oncol,1996,7(5) :453-463.
10Panzuto F, Nasoni S, Falconi M, et al. Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization[J]. Endocr Relat Cancer, 2005,12(4):1083-1092.
7Carling R S, Degg T J, Allen K R, et al. Evaluation of whole blood serotonin and plasma and urine 5-hydroxyindole acetic acid in diagnosis of carcinoid disease[J]. Ann Clin Biochem, 2002,39 (6): 577-582.
8Bonfigli A R, Coppa G, Testa R, et al. Determination of vanillylmandelie, 5 hydroxyindoleaeetic and homovanillic acid in urine by isoeratic liquid chromatography[J]. Eur J Clin Chem Clin Biochem,1997,35(1) :57-61.
9Garcia A, Heiniinen M, Jimenez L M, et al. Direct measure ment of homovanillic, vanillylmandelic and 5-hydroxyindoleacetic acids in urine by capillary electrophoresis[J]. J Chromatogr A, 2000,871(1-2) :341- 350.
10Lionetto L, Lostia A M, Stigliano A, et al. HPLC mass spectrometry method for quantitative detection of neuroendocrine tumor markers: vanillylmandelic acid, homovanillic acid and 5 -hydroxyindoleacetic acid[J]. Clin Chim Acta, 2008,398 (1-2) : 53-56.
